Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Net Margin (2019 - 2025)

Historic Net Margin for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 8.58%.

  • Eton Pharmaceuticals' Net Margin fell 146500.0% to 8.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.19%, marking a year-over-year decrease of 26000.0%. This contributed to the annual value of 9.8% for FY2024, which is 68400.0% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Net Margin of 8.58% as of Q3 2025, which was down 146500.0% from 13.66% recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Net Margin high stood at 43.0% for Q1 2021, and its period low was 786.32% during Q3 2021.
  • Its 5-year average for Net Margin is 70.15%, with a median of 10.18% in 2024.
  • Data for Eton Pharmaceuticals' Net Margin shows a peak YoY increase of 235842700bps (in 2021) and a maximum YoY decrease of 2000000000bps (in 2021) over the last 5 years.
  • Eton Pharmaceuticals' Net Margin (Quarter) stood at 17.05% in 2021, then plummeted by -37bps to 10.73% in 2022, then tumbled by -171bps to 7.57% in 2023, then soared by 32bps to 5.13% in 2024, then plummeted by -67bps to 8.58% in 2025.
  • Its Net Margin stands at 8.58% for Q3 2025, versus 13.66% for Q2 2025 and 88.02% for Q1 2025.